Chargement en cours...
The HIV Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in part, by Inhibition of Survivin
INTRODUCTION: Ritonavir is a potential therapeutic agent in lung cancer, but its targets in lung adenocarcinoma are unknown, as are candidate biomarkers for its activity. METHODS: RNAi was used to identify genes whose expression affects ritonavir sensitivity. Synergy between ritonavir, gemcitabine a...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3104055/ https://ncbi.nlm.nih.gov/pubmed/21270666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31820c9e3c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|